NASDAQ : BGM
BGM Group Ltd. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · China
Last price 9.54 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 127.40M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 127.40M |
| Enterprise Value | 117.03M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 12.69M |
| Shares Outstanding | 13.35M |
| Shares Change (YoY) | +879.66% |
| Shares Change (QoQ) | -4.77% |
| Owned by Insiders (%) | 30.70% |
| Owned by Institutions (%) | 4.23% |
| Float | 9.25M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.66 |
| Forward PS | n/a |
| PB Ratio | 0.16 |
| P/TBV Ratio | 3.79 |
| P/FCF Ratio | 87.24 |
| P/OCF Ratio | 40.17 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 80.14 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.25 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.80 |
| Interest Coverage | -991.63 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -7.41% |
| Return on Assets (ROA) | -2.18% |
| Return on Invested Capital (ROIC) | -2.39% |
| Return on Capital Employed (ROCE) | -2.81% |
| Weighted Average Cost of Capital (WACC) | 12.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.86 |
Taxes
| Measure | Value |
|---|
| Income Tax | 4.83M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -96.61% |
| 50-Day Moving Average | 8.46 |
| 200-Day Moving Average | 20.19 |
| Relative Strength Index (RSI) | 56.44 |
| Average Volume (20 Days) | 12,584 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 8,247 |
| Short Previous Month | 112,147 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.09% |
| Short Ratio (days to cover) | 1.23 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 47.90M |
| Gross Profit | 8.11M |
| Operating Income | -11.22M |
| Pretax Income | -16.78M |
| Net Income | -21.18M |
| EBITDA | -9.25M |
| EBIT | -11.22M |
| Loss Per Share | -$3.36 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 11.55M |
| Total Debt | 1.18M |
| Net Cash | 10.37M |
| Net Cash Per Share | $0.78 |
| Equity (Book Value) | 399.77M |
| Book Value Per Share | 59.55 |
| Working Capital | 9.15M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 3.17M |
| Capital Expenditures | -1.71M |
| Depreciation & Amortization | 1.97M |
| Net Borrowing | 444,215 |
| Free Cash Flow | 1.46M |
| FCF Per Share | $0.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | 16.92% |
| Operating Margin | -23.42% |
| Pretax Margin | -35.02% |
| Profit Margin | -44.22% |
| EBITDA Margin | -19.31% |
| EBIT Margin | -23.42% |
| FCF Margin | 3.05% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -879.66% |
| Shareholder Yield | -879.66% |
| Earnings Yield | -35.20% |
| FCF Yield | 1.15% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 21.71 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |